Details for Patent: 10,711,013
✉ Email this page to a colleague
Which drugs does patent 10,711,013 protect, and when does it expire?
Patent 10,711,013 protects NUBEQA and is included in one NDA.
This patent has ninety-five patent family members in thirty-six countries.
Summary for Patent: 10,711,013
Title: | Androgen receptor modulating compounds |
Abstract: | The present disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts thereof. The present disclosure also relates to compositions and methods of treating comprising compounds of formula (I), and pharmaceutically acceptable salts thereof. ##STR00001## |
Inventor(s): | Wohlfahrt; Gerd (Helsinki, FI), Tormakangas; Olli (Turku, FI), Salo; Harri (Turku, FI), Hoglund; Iisa (Turku, FI), Karjalainen; Arja (Espoo, FI), Koivikko; Pia (Littoinen, FI), Holm; Patrik (Lielahti TL, FI), Rasku; Sirpa (Vantaa, FI), Vesalainen; Anniina (Paimio, FI) |
Assignee: | ORION CORPORATION (Espoo, FI) |
Application Number: | 16/140,716 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; | More… ↓ |
Drugs Protected by US Patent 10,711,013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare | NUBEQA | darolutamide | TABLET;ORAL | 212099-001 | Jul 30, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,711,013
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2493858 | ⤷ Subscribe | 301041 | Netherlands | ⤷ Subscribe |
European Patent Office | 2493858 | ⤷ Subscribe | CA 2020 00020 | Denmark | ⤷ Subscribe |
European Patent Office | 2493858 | ⤷ Subscribe | LUC00154 | Luxembourg | ⤷ Subscribe |
European Patent Office | 2493858 | ⤷ Subscribe | PA2020514 | Lithuania | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |